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Summary
 Introduction: In this paper, an attempt was made to evaluate the antibacterial potential of standard strains of 
lactic acid bacteria (LAB) producing bacteriocins of various classes, thus demonstrating various 
mechanisms of cell membrane damages against the Streptococcus agalactiae strains (Group B 
Streptococcus, GBS), depending on surface polysaccharides and surface alpha-like protein genes.
 Materials/Methods: Antimicrobial property of the strains of L. plantarum C 11, L. sakei DSMZ 6333, and L. lactis 
ATCC 11454 producing bacteriocins: JK and EF plantaricins, sakacin and nisin, respectively, aga-
inst the GBS strains was evaluated. The chosen to the study GBS strains were represented by se-
rotypes Ia, Ib, II, III, V and they had bca, epsilon, rib, alp2 or alp3 alpha-like protein genes. The 
experiment was conducted by means of suspension culture and the bacteria count was determi-
ned using the serial dilution method.
 Results: A great ability of L. plantarum C 11 strain was proven to inhibit the GBS growth. The strain 
of L. sakei DSMZ 6333 did not demonstrate any ability to inhibit the growth of GBS, whereas 
L. lactis ATCC 11454 inhibited the growth of S. agalactiae indicator strains to a minor extent. 
Statistically significant differences were demonstrated between the GBS strains representing va-
rious serotypes against the antimicrobial activity of model LAB strains. The least sensitive to the 
activity of bacteriocins were the strains representing serotypes Ib and III, whereas the strains re-
presenting serotype II were the most sensitive. The sensitivity of the GBS strains to the antimi-
crobial activity of LAB was not dependent on alpha-like protein genes.
 Discussion: Among the LAB standard strains producing bacteriocins, the strongest antimicrobial property 
was observed in the strain of L. plantarum C 11. Because of the generally known and verified 
strong antagonistic property of the strains of L. plantarum species against indicator bacteria, it 
is necessary to further pursue the research presented in this paper.
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IntroductIon
Antimicrobial peptides (AMP’s) are produced and excreted 
by bacteria, fungi, plants, insects and vertebrata. AMP’s 
posses an amphipathic structure and contain in their mo-
lecules from 12 to 120 amino acids. AMP’s are known to 
have an inhibitory effect directed against enveloped viru-
ses, bacteria, fungi, parasites as well as cancer cells [32].
Bacteriocins are a subgroup of AMP’s. They are small pep-
tides encoded by ribosomal DNA or plasmids characterized 
by antibacterial activity, most frequently against bacteria 
which are closely related phylogenetically (narrow spec-
trum of activity) or against other microbes (wide spectrum 
of activity) [18]. Bacteriocins are active against microbes 
already in picomolar or nanomolar concentrations.The me-
chanism of bacteriocins activity involves the perforation of 
cell membranes of microorganisms. Damage to bacterial 
membrane leads to the loss of ions, ATP and components 
which are indispensable for proper functioning and cell me-
tabolism. Interestingly, bacteria producing a certain bac-
teriocin demonstrate immunity against the activity of the 
same [11]. Bacteriocins were divided into four classes ta-
king into account their chemical structure, molecular mass, 
sensitivity to enzyme activity, contents of modified amino-
acids and activity mechanism (Table 1). A substantial num-
ber of antimicrobial peptides are excreted by probiotic bac-
teria and subsumed into class I and II bacteriocins [30,31].
Many experiments were conducted which have proven the 
antibacterial effect of bacteriocins excreted by the genus 
of Lactobacillus on many species and indicator bacteria 
strains (Table 2).
Streszczenie
 Wstęp: W pracy podjęto próbę oceny antybakteryjnego potencjału szczepów wzorcowych bakterii kwasu 
mlekowego (lactic acid bacteria – LAB) wytwarzających bakteriocyny różnych klas, a tym samym 
wykazujących różne mechanizmy uszkodzenia błony komórkowej wobec szczepów Streptococcus 
agalactiae (Group B Streptococcus – GBS). Wrażliwość Streptococcus agalactiae na działanie 
antybakteryjne szczepów wzorcowych LAB oceniono względem przynależności szczepów GBS 
do serotypów oraz obecności genów białek z rodziny alfa-podobnych.
 Materiały/Metody: Oceniono właściwości przeciwdrobnoustrojowe szczepów L. plantarum C 11, L. sakei DSMZ 
6333, L. lactis ATCC 11454 będących producentami bakteriocyn odpowiednio plantarycyn JK 
i EF, sakacyny oraz nizyny wobec szczepów GBS. Wybrane do eksperymentu szczepy GBS na-
leżały do serotypów Ia, Ib, II, III, V oraz zawierały geny białek bca, epsilon, rib, alp2, alp3 z ro-
dziny alfapodobnych. Eksperyment przeprowadzono metodą hodowli w zawiesinie, oznaczając 
liczbę drobnoustrojów metodą seryjnych rozcieńczeń.
 Wyniki: Wykazano znaczną aktywność przeciwdrobnoustrojową szczepu L. plantarum C 11 wobec szcze-
pów GBS. Szczep L. lactis ATCC 11454 hamował wzrost S. agalactiae w niewielkim stopniu, 
a szczep L. sakei DSMZ 6333 był pozbawiony takiej aktywności. Wykazano różnice istotne sta-
tystycznie we wrażliwości szczepów GBS reprezentujących różne serotypy wobec działania prze-
ciwdrobnoustrojowego szczepów wzorcowych LAB. Najmniej wrażliwe na działanie bakteriocyn 
były szczepy należące do serotypów Ib oraz III, najbardziej zaś szczepy z serotypu II. Wrażliwość 
szczepów S. agalactiae na działanie przeciwdrobnoustrojowe LAB nie była zależna od genów 
białek z rodziny alfapodobnych.
 Dyskusja: Spośród szczepów wzorcowych bakterii kwasu mlekowego wytwarzających bakteriocyny najsil-
niejsze właściwości antybakteryjne wobec paciorkowców z grupy serologicznej B wykazywał 
szczep L. plantarum C 11. Ze względu na powszechnie znane i potwierdzone silne właściwości 
antagonistyczne szczepów bakterii z gatunku L. plantarum wobec bakterii wskaźnikowych ko-
nieczna jest kontynuacja przedstawionych w pracy badań.
 Słowa kluczowe:	 bakteriocyny	•	plantarycyny	•	działanie	przeciwdrobnoustrojowe	•	bakterie	kwasu	mlekowego	
•	Streptococcus	agalactiae
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Probiotics are described as live microbes which, when ad-
ministered in appropriate amounts, have a beneficial effect 
upon the health of host. With reference to this definition, 
many strains of lactic acid bacteria (LAB) fulfilling the cri-
teria of probiotic bacteria have found application as die-
tary supplements [42]. In recent years, in connection with 
the increasing frequency of occurrence of pathogenic mi-
crobes resistance to antibiotics, there is a higher and hi-
gher interest in using probiotics or purified bacteriocins as 
alternative medical preparations. Research conducted by 
Millette at al. (2008) with using mouse models, where the 
inhibitory impact of post-culture liquids of L. lactis MM 19 
and P. acidilactici MM 33 producing nisin and pediocin, 
respectively, against vancomycin-resistant Enterococci, or 
VRE was determined, demonstrated a reduction in the in-
testinal enterococcal population [27].
Then Kruszewska et al. (2004) showed antagonistic activi-
ty of mersacidin synthesized by Bacillus sp. against strains 
of Staphylococcus aureus (methicillin – resistant S. aureus, 
or MRSA) leading to the elimination of bacterial coloniza-
tion in the mucous membrane of mouse nose [24]. Results 
Fernandez et al. (2008) demonstrated the efficacy of nisin 
in the medication of mastitis in women, which was caused 
by Staphylococci belonging to Gram-positive bacteria [13]. 
In order to form a modern preparation containing nisin, with 
Producer Strain Source Bacteriocin Class of bacteriocin Action of bacteriocin
E. faecium H41B cheese enterocin A
enterocin P
II antagonistic activity against Listeria 
spp. [35]
L. gasseri LA 39 faeces of 
newborn
gassericin A IV antagonistic activity against 
L. monocytogenes, S. ureus, B. cereus 
[21]
L. acidophilus M 46 faeces of 
newborn
acidocin B IV antagonistic activity against 
L. monocytogenes, C. sporogenes, L. 
fermentum and Lactobacillus delbrueckii 
ssp. bulgaricus [25]
L. plantarum C 11 fermented 
cucumber
plantaricin JK
(PlnJ, PlnK)
plantaricin EF
(PlnE, PlnF)
II b antagonistic activity against indicator 
strains of L. plantarum 965, L. sake 
NCDO 2714, L. viridescens NCDO 1655, L. 
plantarum UI50 [2]
plantaricin A
(PlnA)
pheromone synthesis induction of Pln J, PlnK, PlnE, 
PlnF; antibacterial activity [23];
cytotoxic activity against cancer cells 
[45]
L. sakei DSMZ 6333 pork, vacuum-
packaged
sakacin A II a anti- Listeria activity; antagonistic 
activity against L. sake, L. curvatus, 
C. piscicola, E. faecalis, L. monocytogenes 
[20,29]
L. lactis ATCC 11454 meat nisin I (typ A) a broad anti-microbial spectrum; is 
used as food preservative [42]
Table. 2. Examples of bacteriocins from individual classes produced by LAB, place of LAB strains isolation and the extent of antimicrobial activity
Bactriocin classes Bacteriocin subclasses Molecular mass Characteristics of class/subclass Bacteriocin
Class I A <5 kDa lantibiotics nisin [16,43]
B marsacydin alametycin [16,42]
Class II IIa <10 kDa pediocin-like bacteriocins sakacin A, sakacin P [30]
IIb two-peptide bacteriocins lactacin F [30]
IIc sec-dependent bactriocins carno-bacteriocin A [30]
Class III >30 kDa heat-labile protein bacteriocins lactococcin B [31]
Class IV large protein mixture of protein(s), lipid(s) and 
carbohydrate(s) in bacteriocin 
molecule
leucocin S, mesenterocin 52 [31]
Table 1. Classification and general characteristics of bacteriocins
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increased antibacterial efficacy, research on encapsulation of 
peptide in nanoliposomes is conducted [9]. Bacteriocins as 
medications would be entirely safe for patients and additio-
nally their use would not result in the development of micro-
bes resistance, due to their specific activity mechanism [36].
The bacterial flora of female reproductive tract consists 
for the most part of LAB but also of potentially pathoge-
nic microbes like, for instance: Streptococcus agalactiae, 
Escherichia coli, Enterococcus faecalis, and fungi of the 
genus of Candida [6]. Using bacteriocins against poten-
tially pathogenic microbes colonizing female reproductive 
tract would seem promising, especially in those patients in 
whom recurrent vaginitis are observed. An additional as-
set of bacteriocins is that they are excreted in minor con-
centrations into the vaginal milieu by some strains of the 
genus of Lactobacillus being the basic content of vaginal 
microflora [14,22,41]. Due to this fact the antimicrobial 
peptides have their share in keeping the physiologic ba-
lance of vaginal flora. Using preparations containing bac-
teriocins would be aimed at helping eradicating potential-
ly pathogenic microbes from the vaginal milieu and thus 
preventing vaginitis in women. A special threat among 
the microbes colonizing the vagina pose the b-hemoly-
tic Streptococci agalactiae subsumed into the Group B 
Streptococci (GBS). According to epidemiologic data the-
re is a connection between colonization by GBS of anu-
ses and vaginae in pregnant women and neonate infections 
caused by this bacteria. During a delivery there is a high 
risk of neonate colonization by GBS from the microflo-
ra of mother’s vagina or the cervical canal vertically, with 
a probability of up to 70%. At present, the GBS infection 
prophylaxis in neonates consists in performing screening 
tests in pregnant women and in case of finding a GBS co-
lonization in administration of a proper antibiotic to the 
parturient women prophylactically [17].
Unfortunately, in the recent years, GBS strains are more 
and more frequently found to be resistant to macrolides, 
lincosamides and streptogramin B. It constitutes a factor 
significantly decreasing the efficacy of the recommended 
prophylaxis [3,26]. That is why because of a low effica-
cy of antibiotic medication, especially in the case of car-
riage of GBS and adverse consequences of antibiotic ad-
ministration, it is necessary to look for other, alternative 
ways to prevent GBS colonization of the reproductive tract.
In connection with this, this paper was aimed at the eva-
luation and comparison of antibacterial effect of the stan-
dard strains of LAB: L. plantarum C 11, L. lactis ATCC 
11454 and L. sakei DSMZ 6333 which produce bacterio-
cins such as: JK and EF plantaricins, nisin, and sakacin, 
respectively, subsumed into various classes of antimicro-
bial peptides, thus having different bacterial cell membra-
ne permeabilization mechanisms, on selected strains of 
S. agalactiae and additionally demonstration of relation-
ships of sensitivity of selected GBS strains to GBS sero-
types (Ia, Ib, II, III, or V) and the surface alpha-like pro-
tein genes (bca, alp2, alp3, epsilon, rib).
MaterIals and Methods
The strains of S. agalactiae came from the own collection 
of the Department of Bacteriology, Microbial Ecology 
and Parasitology, Chair of Microbiology, Jagiellonian 
University, Medical College. They were collected in the 
framework of projects to which funding was provided 
by the Ministry of Science and Higher Education No. 
3 PO5E 084 25, No. 2 P05E 004 30 and No. NN 401 042337 
and the research under the charter No. K/ZDS/000648, 
which was conducted with the permission of the Bioethics 
Committee of the Jagiellonian University Medical College 
No. KBET/267/B/2002 and No. KBET/143/B/2007. The 
strains of GBS (n=26) subjected to the research were iso-
lated both from women with clinical symptoms of vagi-
natis, and from pregnant women routinely tested for GBS 
carriage, from neonates who, for various reasons, were 
admitted to the neonate pathology department as well as 
from neonates colonized with GBS with no symptoms 
of infection. Control was constituted by the model stra-
ins of S. agalactiae DSMZ 2134 (German Collection of 
Microorganisms and Cell Cultures, DSMZ), S. agalactiae 
ATCC 12403 and S. agalactiae ATCC BAA-611 (American 
Type Culture Collection, ATCC).
26 GBS strains representing the most frequently isolated 
serotypes Ia (n=8), Ib (n=3), II (n=4), III (n=9), V (n=2) 
to the study were selected. The GBS serotypes were de-
termined by multiplex-PCR reaction according to proce-
dures by Poyart et al. (2007) and Brzychczy-Włoch et al. 
(2011). Surface alpha-like protein genes (bca n=5, epsilon 
n=8, rib n=8, alp2 n=4, alp3 n=1) were detected with the 
application multiplex-PCR reaction according to the pro-
cedure that was described by Creti et al. (2004) [7,10,33].
GBS strains were cultured on the Columbia medium sup-
plemented with 5% sheep blood (Columbia Blood Agar, 
BioCorp). One loopful with the volume of 1 µl of GBS 
culture on solid medium was transferred to 5 ml of TSB 
(Tryptic Soy Broth, Difco). The GBS culture which was 
prepared in such a way was incubated under oxygenous 
condition for 24 hours at 37°C (WS 140, Bolarus Cabinet). 
The density of the obtained bacterial suspension was as-
sessed with the use of spectrophotometric measurement 
(Spectrophotometer UV/VIS V-550, Jasco) at wavelength of 
600 mm within the range of 0.3–0.4 and it was 1×106 cfu/ml.
The LAB standard strains were obtained for the purposes 
of this experiment from university or commercial collec-
tions. The strain of Lactobacillus plantarum C 11 was ob-
tained from the Department of Chemistry, Biotechnology 
and Food Science, Norwegian University of Life Sciences, 
As, Norway. The strain of L. plantarum C 11 excretes di-
peptides with proven antibacterial property such as di-
peptide plantaricins J and K (pln JK) and E and F (pln 
EF) and additionally the pheromone plantaricin A (pln 
A), a substance inducing the L. plantarum C 11 strain to 
produce the above-mentioned bacteriocins. Further stra-
ins of Lactobacillus sakei DSMZ 6333 and Lactococcus 
lactis ATCC 11454 came from the German Collection 
of Microorganisms and Cell Cultures (DSMZ) and the 
American Type Culture Collection (ATCC).
LAB were cultured on the MRS solid medium (Oxoid, 
Poland) and incubated for 24 hours at 37°C under anaero-
bic condition (Anaerobic culture chamber, dw Scientific). 
Then, they were (their amount being one loopful with the 
volume of 1 µl) spread over 5 ml of MRS liquid medium 
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(Oxoid). The strains of L. lactis ATCC 11454 and L. sakei 
DSMZ 6333 were incubated at 32°C and 20°C, respectively, 
under anaerobic condition for 24 hours in MRS liquid me-
dium [1,8]. In order to prepare the culture of L. plantarum 
C 11 for the experiment, bacteria were initially incubated for 
8 hours at 30°C under anaerobic condition. Then, a phero-
mone pln A was added to the culture, the volume of which 
was just enough to obtain the concentration of pln A in the 
L. plantarum C 11 culture reading 1 µl/ml. The culture of 
this strain was continued for 6 hours, up to the moment, 
when the production of plantaricins J and K as well as E 
and F reached the maximum level [15]. In the experiment 
were used: 24-hour cultures of L. lactis ATCC 11454 and 
L. sakei DSMZ 6333 and the cultures of L. plantarum C 11 
in 3 variants: the 1st 14-hour culture with no pln A added 
constituting a negative control; the 2nd 8-hour culture with 
pln A added, with its volume on the outset of the experi-
ment being just enough to obtain the concentration of the 
pheromone of 1 µl/ml in the culture; the 3rd 14-hour cultu-
re containing produced plantaricins under the influence of 
pln A incubation added in the 8th hour. The optical densi-
ty of the standard LAB strains liquid cultures used in the 
experiment for the wavelength of 600 nm was 0.6–0.7. The 
positive controls constituted the chemical solutions of pure 
nisin in Phosphate Buffered Saline (PBS, Sigma Aldrich), 
the concentrations of which were 1 µg/ml and 0.5 µg/ml.
The suspensions of the standard LAB cultures and the su-
spensions of selected GBS strains were mixed in the ratio 
of 9:1 and incubated under microaerophil conditions (in-
cubator CLN ECO, POL-ECO Aparatura) at temperatu-
res proper for individual model LAB strains. The mixtures 
of the LAB: GBS cultures were spread over Columbia so-
lid medium supplemented with 5% sheep blood, the dilu-
tions being 0, –2, –4, and –6, respectively within 10 min., 
1 hr, 2 hrs, 3 hrs and 4 hrs after the moment they had been 
mixed. The spread plates with media were incubated for 
48 hrs under microaerophil conditions at 37°C. Then, the 
grown GBS and LAB colonies were summed up, the num-
ber of which has been given in cfu/ml-units.
The following techniques of inductive statistics were used 
to analyze the results obtained: the analysis of varian-
ce (ANOVA) and as a supplementary analysis the Tukey-
Kramer post-hoc test. If the distribution of the numeri-
cal variable significantly diverged from the Gauss curve, 
non-parametric alternatives of the above tests were used: 
Kruskal-Wallis test as the alternative to ANOVA and Steel 
test instead of Tukey-Kramer test [12,39]. Statistical pro-
cedures were calculated using the JMP 7.01 package (SAS 
Institute Inc.) [40].
results
The activity of LAB producing bacteriocins (L. plantarum 
C 11, L. sakei DSMZ 6333 and L. lactis ATCC 11454) 
was evaluated against 26 GBS strains and model strains 
of S. agalactiae DSMZ 2134, S. agalactiae ATCC 12403 
and S. agalactiae ATCC BAA-611. Results obtained after 
1 hr, 2 hrs, 3 hrs and 4 hrs of the duration of experiment 
were selected as data for statistical analysis and they were 
related to the initial GBS number.
Among the three selected standard LAB strains producing 
bacteriocins the strain of L. plantarum C 11 demonstrated 
the strongest GBS growth inhibiting property. The growth 
inhibiting activity against selected GBS strains was chec-
ked in 3 L. plantarum C 11 culture variants (I, II, III) in 
mixtures of LAB-GBS. In the course of the experiment 
the GBS number changed comparably, irrespective of the 
L. plantarum C 11 culture variant. After 2 hours since the 
start of procedure the GBS number decreased by ca. 2–3 
logarithms. Because of reaching the highest concentra-
tion of plantaricins (pln EF and pln JK) by L. plantarum 
C 11 culture variant III, it was chosen to comparative ana-
lysis of antimicrobial activity model LAB strains (Fig. 1). 
Throughout the experiment no significant reduction in the 
GBS number was noted under the influence of the activi-
ty of bacterial suspensions of L. sakei DSMZ 6333 and 
L. lactis ATCC 11454. Only in the presence of L. lactis 
ATCC 11454 the GBS number decreased by 1 logarithm 
throughout the experiment. Interestingly, nisin in concen-
trations of 1 µg/ml and 0.5 µg/ml in the GBS cultures de-
monstrated no antibacterial property against these microbes.
Taking into consideration the distinguishability of GBS 
strains as far as serotypes are concerned, significant diffe-
rences were statistically proven in the antibacterial activi-
ty of the model LAB strains producing bacteriocins after 
2 hours since the start of the experiment (p=0.0155). The 
least sensitive to the antagonistic activity of LAB turned 
out to be the strains representing serotypes Ib and III, and 
the most sensitive the strains representing serotype II. The 
difference in the sensitivity to the antibacterial activity of 
LAB between these serotypes was statistically significant 
(p<0.05) (Fig. 2).
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Fig. 1.  Relation of the GBS number (log cfu/ml) after 
the first four full hours of the experiment (1 
hr, 2 hrs, 3 hrs, 4 hrs) since the start with the 
antibacterial activity of the model LAB strains. 
Results described the logs of GBS number, 
which were not inhibited by investigated 
model of LAB strains. There was no statistical 
relationship between antimicrobial activity 
of L. lactis ATCC 11454 and L. plantarum C11 
culture (variant III) after the first hour of the 
experiment. Statistically significant relationship 
was confirmed in activity of each of checked LAB 
strains against GBS (log cfu/ml) after following 
hours of experiment. * statistically significant 
relation
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Subjecting to an analysis the sensitivity of GBS strains, 
depending on genes coding Alp family proteins they had, 
to the antagonistic activity of LAB it was demonstrated 
that after 2 hours since the start of the experiment the 
differences observed were nearly statistically significant 
(p=0.0683). The lowest sensitivity to the inhibiting acti-
vity of LAB was demonstrated by GBS strains with alp2 
gene (decrease in the GBS number by 1 logarithm), whe-
reas the highest one by GBS isolates with alp3 gene (de-
crease in the GBS number by 3 logarithms).
Because of the existing correlation of occurrence of surfa-
ce saccharides and Alp family proteins and their genes, an 
additional statistical analysis was made. It encompassed the 
antimicrobial property of model LAB strains against GBS 
based on two variables. GBS strains representing serotypes 
III and Ib with surface protein genes alp2, bca and epsilon 
demonstrated a lower sensitivity to effects on the side of 
bacilli from the genus Lactobacillus in contradistinction to 
the strains representing serotype II with bca and rib genes.
dIscussIon
The basis of the experiment that was planned and encom-
passed by this paper were promising results of many pie-
ces of scientific research demonstrating effective antimicro-
bial activity of LAB strains producing bacteriocins or of 
their products, purified bacteriocins, against strains of bac-
teria, also against the antibiotic-resistant ones [13,24,27]. 
The evaluation conducted regarding the antimicrobial pro-
perty of the standard LAB strains producing bacteriocins 
(Lactobacillus sakei DSMZ 6333, Lactococcus lactis ATCC 
11454 and Lactobacillus plantarum C 11) against GBS also 
constituted the continuation of research into the sensitivity 
of selected GBS strains to the antagonistic activity of selec-
ted LAB strains isolated in the vagina, their genera being 
L. gasseri, L. plantarum, L. fermentum and L. rhamnosus [5].
From among the standard LAB strains producing pepti-
des demonstrating antibacterial property, the strongest in-
hibiting property against GBS was demonstrated by the 
strain of L. plantarum C11 which was isolated from pic-
kled cucumbers. No sensitivity of the indicator GBS stra-
ins was demonstrated to the antibacterial activity of the 
strain of L. sakei DSMZ 6333 and a minor sensitivity to 
the inhibiting activity of L. lactis ATCC 11454, i.e. strains 
also isolated from foodstuffs. In the evaluation of the an-
tagonism of LAB isolated from the vagina against GBS, a 
very strong antagonistic activity of the lactic acid bacteria 
was demonstrated compared with the standard LAB stra-
ins producing bacteriocins. Already within 2 hours’ time 
after the experiment was started, in the milieu of several 
Lactobacillus strains isolated from the vagina a decrease 
in the number of S. agalactiae by several logarithms or a 
complete reduction of the GBS population was observed 
[5]. The selected LAB strains isolated from the vagina, the-
ir genera being L. plantarum, L. gasseri, L. rhamnosus and 
L. fermentum, like the standard LAB strains, their genera 
being L. plantarum, L. sakei oraz L. lactis demonstrated 
diversified antagonistic activity against GBS. From this it 
appears that the antimicrobial activity of LAB is not a at-
tribute of the species, but it depends on the strain. Further, 
Awaisheh et al. (2009) while comparing the antibacterial 
property of LAB isolated from both humans, foodstuffs and 
fermented vegetables did observe the ability to inhibit the 
growth of indicator bacteria by all the analyzed LAB stra-
ins. The LAB, however, which were isolated from humans 
had the strongest antagonistic property [4].
The standard LAB strains producing bacteriocins, such as 
L. sakei DSMZ 6333 and L. lactis ATCC 11454 in contra-
distinction to the LAB originating from the vagina did not 
demonstrate any antibacterial activity against GBS, or only 
a minor one. The lack of inhibiting property of L. sakei 
DSMZ 6333 producing sakacin could have been undoub-
tedly caused by the very narrow spectrum of this peptide 
activity, limited mainly to LAB. For instance, the research 
conducted by Schillinger et al. (1989) to evaluate the anta-
gonistic property of the strain of L. sake Lb 706 excreting 
sakacin demonstrated that this strain inhibited the growth of 
among others: L. sake, L. curvatus, L. paramesenteroides, 
E. faecalis and Listeria monocytogenes. The strain of L. sake 
Lb 706, however, was not active against other Gram-positive 
and Gram-negative bacteria, e.g. against Staphylococcus 
aureus or against Salmonella typhimurium [37].
Then, the model strain of L. lactis 11454 excreting nisin 
reduced the population of several GBS strains researched 
into by 1 logarithm throughout the experiment, whereas 
the solution of chemically pure nisin had no such property. 
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Fig. 2.  Comparison of reduction in GBS number in 
individual serotypes (log cfu/ml) after 2 hours’ 
duration of the experiment. Results expressed 
as log of number of bacteria, by which the GBS 
population was decreased with reference to the 
initial number of the population after 2 hours’ 
duration of the experiment. The correspondence 
between the GBS serotypes and various sets 
denotes statistically significant relations 
between them; mean – mean formula, SE – 
standard estimation, SD – standard deviation
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It could be connected with factors present in the culture 
of L. lactis ATCC 11454, having an antibacterial effect on 
GBS, i.e. factors other than nisin or ones acting synergi-
stically in relation to nisin [34].
From among the selected standard LAB strains, the stron-
gest antagonistic activity against GBS, comparable with 
the activity of the strains of bacteria from the genus of 
L. plantarum isolated from the vagina was demonstrated 
by the strain of L. plantarum C 11. Results of the research 
by Huett et al. (2006) and Xu et al. (2008) have proven that 
the activity of the genus L. plantarum strongly inhibits the 
growth of C. albicans, E. coli, S. aureus and P. aeruginosa 
[19,44]. Anderssen et al. (1998) demonstrated that planta-
ricins J and K as well as E and F excreted by the strain of 
L. plantarum C11 are able to inhibit the growth of indica-
tor strains, among others of L. plantarum, Pediococcus 
pentosaceus, Lactobacillus viridescens. Also, plantaricin A 
demonstrates antagonistic property against microbes. That is 
why both the interaction between plantaricins J and K as well 
as E and F, and also between plantaricins J, K and plantari-
cin A and plantaricins E, F and plantaricin A is of a syner-
gistic nature intensifying their antibacterial activity [2,28].
In the experiment described in this paper, in the 24-hour liqu-
id cultures of selected LAB strains, products of bacterial me-
tabolism were accumulated. Moreover, throughout the expe-
riment metabolites of antibacterial nature were synthesized 
and excreted. The strong property inhibiting the growth of 
GBS already after 2 hours after the start of experiment may 
be explained by the presence of L. plantarum C 11 meta-
bolites (bacteriocins, short fatty acids, hydrogen peroxide). 
However, the preservation of non-oxygenic condition of the 
culture no doubt influenced the limitation of production by 
the LAB strains of hydrogen peroxide or of lactic acid [37].
The sensitivity of the GBS representing individual seroty-
pes to the activity inhibiting LAB was no doubt connected 
with differences in the structure of polysaccharide bacte-
rial capsule. The GBS strains representing the serotype III 
are for the most part isolated from cases of carriage in pre-
gnant women and causing infections in neonates [7]. It may 
also be connected with the occurrence of specific mecha-
nisms of evasion and resistance to the antibacterial activity 
of strains such as among others LAB colonizing the same 
environmental niches of the human body. Furthermore, 
promising are the results indicating a considerable sensiti-
vity of the GBS strains representing the serotype V which 
is more and more frequently described as a factor of infec-
tions, especially in the group of adult patients, to the anta-
gonistic activity of LAB originating from the vagina [38].
The results of the presented experiment indicate that the 
strains of S. agalactiae are sensitive to the antimicrobial 
activity of L. plantarum C 11 strain producing dipeptides 
JK and EF. Because of a small pool of the analyzed GBS 
strains, it would be advisable to include a larger pool of 
strains into research. Additionally, it would be interesting 
to obtain results of evaluation of the influence on GBS of 
mixtures of LAB strains producing bacteriocins presenting 
various classes. The obtained data would reveal synergi-
stic influence, if any, of LAB strains on pathogenic micro-
bes. It would also be useful to check the influence of the 
model LAB strains obtained from cultures along with pu-
rified bacteriocins as well as their mixtures. The obtained 
results could be useful in the future in order to research 
into new probiotic preparations used to control and pre-
vent inflammatory conditions of female reproductive tract.
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